MA40332A - Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane - Google Patents

Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane

Info

Publication number
MA40332A
MA40332A MA040332A MA40332A MA40332A MA 40332 A MA40332 A MA 40332A MA 040332 A MA040332 A MA 040332A MA 40332 A MA40332 A MA 40332A MA 40332 A MA40332 A MA 40332A
Authority
MA
Morocco
Prior art keywords
beta
alpha
reduction
unsaturated ketone
ketone levels
Prior art date
Application number
MA040332A
Other languages
English (en)
Inventor
Keith Edward Mccarthy
Helge Alfred Reisch
Christopher Sprout
Original Assignee
Rhodes Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodes Tech filed Critical Rhodes Tech
Publication of MA40332A publication Critical patent/MA40332A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA040332A 2014-07-09 2015-07-08 Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane MA40332A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462022514P 2014-07-09 2014-07-09

Publications (1)

Publication Number Publication Date
MA40332A true MA40332A (fr) 2021-04-28

Family

ID=53761450

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040332A MA40332A (fr) 2014-07-09 2015-07-08 Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane

Country Status (5)

Country Link
US (2) US20170342084A1 (fr)
EP (1) EP3166948A1 (fr)
CA (1) CA2954600A1 (fr)
MA (1) MA40332A (fr)
WO (1) WO2016005923A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018071581A1 (fr) * 2016-10-12 2018-04-19 Columbia Care, Llc Composition orale d'extraits de cannabinoïdes et procédés d'utilisation
EP3495371A1 (fr) 2017-12-05 2019-06-12 Siegfried AG Synthèse de noroxymorphone
WO2021158957A1 (fr) 2020-02-05 2021-08-12 Summit Biosciences Inc. Produits médicamenteux destinés à être administrés par voie intranasale et utilisations associées
EP4103181A4 (fr) * 2020-02-14 2024-03-06 Teikoku Pharma USA, Inc. Compositions topiques de naloxone et leurs procédés d'utilisation
JP2023548356A (ja) * 2020-11-02 2023-11-16 ローズ テクノロジーズ ノルオキシモルホンを精製するための方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI365880B (en) * 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
WO2006084389A1 (fr) * 2005-02-11 2006-08-17 Cilag Ltd. Procede pour epurer des composes de noroxymorphone
ME01594B (me) 2005-03-04 2014-09-20 Euro Celtique Sa Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijama
KR101417135B1 (ko) 2005-11-22 2014-07-08 콘드롤드 케미컬즈, 인크. 옥시코돈 및 다른 조성물에서 오염물질인 마이클 수용체수준을 감소시키는 방법
CN101395159A (zh) * 2006-03-02 2009-03-25 马林克罗特公司 制备含有低含量α,β-不饱和酮化合物的吗啡烷-6-酮产物的方法
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
UA117225C2 (uk) * 2012-07-16 2018-07-10 Родес Текнолоджіс Спосіб покращеного синтезу опіоїду
GB201313915D0 (en) 2013-08-02 2013-09-18 Johnson Matthey Plc Process

Also Published As

Publication number Publication date
CA2954600A1 (fr) 2016-01-14
US20170342084A1 (en) 2017-11-30
US20200223859A1 (en) 2020-07-16
EP3166948A1 (fr) 2017-05-17
WO2016005923A1 (fr) 2016-01-14

Similar Documents

Publication Publication Date Title
CL2016002310A1 (es) Nuevos compuestos bicíclicos.
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
LT3116900T (lt) Kompozicijos, naudotinos ornitino transkarbamilazės (otc) nepakankamumo gydymui
BR112016018521A2 (pt) composição, e, kit.
EP3139920A4 (fr) Composés anti-viraux, compositions pharmaceutiques et méthodes d'utilisation de ceux-ci
BR112017004612A2 (pt) compostos, composição farmacêutica, usos de um composto, e kit
BR112016023628A2 (pt) composições farmacêuticas.
BR112016025246A2 (pt) composição de preservativo de madeira
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
BR112016023341A2 (pt) composição desinfetante de ação rápida
BR112016028543A2 (pt) composições orais contendo íons de metal.
IL249646A0 (en) Platinum compounds, preparations, and their uses
EP3135650A4 (fr) Adjuvant pour composition hydraulique
EP3685682C0 (fr) Composition de réhydratation par voie orale
SI3220893T1 (sl) Sestavek na osnovi COQ10
DK3241551T3 (da) Farmaceutisk sammensætning til behandling af kræft, indeholdende lactatmetalsalt
IL248783A0 (en) Fluorescence quenching compounds, preparations containing them and their uses
PL3016663T3 (pl) Sterylizowana kompozycja termożelowalna
EP3494174C0 (fr) Composition réduisant la traînée
MA40332A (fr) Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane
BR112016030507A2 (pt) Compostos relacionados à vitamina d, composição farmacêutica, e kit
EP3134147C0 (fr) Produit lavant à usage intime
BR112016015712A2 (pt) método de tratamento de doenças hepáticas.
EP3416502A4 (fr) Composition de réduction glycémique
BR112017013928A2 (pt) composição alimentar e método de uso.